Roche Venclexta/Venclyxto combination shows promising results in phase III VIALE-A study in Leukemia patients Medical Dialogues Bureau29 March 2020 12:15 PM ISTVenclexta/Venclyxto is being developed by AbbVie and Roche.
Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia Medical Dialogues Bureau17 May 2019 9:15 AM IST"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths Farhat Nasim21 March 2019 9:45 AM ISTThe clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukaemia (CLL) or acute myeloid...
FDA approves new blood cancer treatment from Pfizer Medical Dialogues Bureau22 Nov 2018 9:15 AM ISTThe U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
Roche, AbbVie leukemia drug superior to older medicine in study Ruby Khatun Khatun24 Nov 2017 9:45 AM ISTPatients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without...
